R, S., 		A, H., & 		David, L.
(2023).
 Transcriptomics and Brain Volumetrics Define the Causes of Cognitive Impairment in Patients with CIRS and Support the use of VIP in Treatment.
<em>Medical Research Archives, 11</em>(2).
doi:10.18103/mra.v11i2.3659